The absolute worst thing you can do is shake the vial
National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007
Our team ensures safe, effective results with minimal downtime
These products contain ingredients that companies claim may support the body's natural GLP-1 production, but they are not FDA-approved drugs and have not undergone the clinical trial requirements that pharmaceutical medications face
Leading Market Players Listed in this Report are: Novo Nordisk A/S (Ozempic, Wegovy, Rybelsus, Victoza, Saxenda) Eli Lilly and Company (Mounjaro, Zepbound, Trulicity) AstraZeneca PLC (Byetta, Bydureon BCise) Sanofi SA GlaxoSmithKline plc Pfizer Inc
According to a 2025 study, 91% of people taking the highest dose of tirzepatide achieved at least 5% weight loss